With major policy shifts, AI integration, and CDMO growth. Ireland stands at a crossroads – this summit defines what comes next.
A high-impact gathering of global biopharma leaders to address Ireland’s innovation gap in CGT and biologics – and define its future as a true end-to-end ecosystem.
A high-impact gathering of global biopharma leaders to address Ireland’s innovation gap in CGT and biologics – and define its future as a true end-to-end ecosystem.
Ireland’s only leading summit connecting innovation with real-world biomanufacturing – uniting leaders shaping the future of CGT and biologics.

Senior manufacturing, tech ops, and MSAT leaders from Ireland’s biopharma, CDMO, and equipment provider ecosystem — plus global executives exploring expansion into Ireland.

A 2-day summit in Dublin uniting Ireland’s biologics manufacturing community with global innovators. The event bridges the country’s production strength with urgent needs in R&D, tech adoption, and talent retention — connecting industry, academia, and government in one strategic forum.

Ireland leads in biologics output — but risks falling behind on innovation. Without bold moves in upskilling, cross-border R&D, and digital readiness, global investment may shift elsewhere. This summit is where solutions take root.
KEY THEMES & TOPICS

300+
Senior attendees spanning CGT manufacturing, tech ops, QA, regulatory, and clinical development.

60+
Expert speakers driving innovation across CGT, biologics, digital transformation, and regulatory functions.

100+
Companies represented, from global pharma leaders to emerging biotechs, CDMOs, and regulators.

2 Dedicated Tracks
Focused agendas across BioManufacturing, CGT Manufacturing – tailored for Ireland’s strengths in end-to-end biologics

Strategic Roundtables & Panels
On early-stage R&D gaps, talent retention issues, digital GMP, clinical trial bottlenecks, and next-gen supply chain models

Hosted in Dublin
Ireland’s thriving biotech and life sciences capital; a strategic nexus for global biologics and CGT partnerships.




